Logo

American Heart Association

  2
  0


Final ID: Mo3146

Understanding Medication Adherence to Oral Anticoagulants in Atrial Fibrillation Management: Patient and Provider Perspectives in a Mixed Methods Study

Abstract Body (Do not enter title and authors here): Background: Atrial fibrillation (AF) increases risk of stroke. National guidelines recommend oral anticoagulant (OAC) use to reduce this risk. Medication adherence is pivotal for effective AF management, necessitating an understanding of adherence barriers.
Aims: This mixed-methods study aimed to identify patient and provider factors influencing OAC adherence.
Methods: Patients with nonvalvular AF and OAC prescriptions were sampled from a large community health system serving seven states. A stratified random sample of 2,000 patients was surveyed by mail, achieving a 13.3% response rate (266 patients). Twenty-eight semi-structured interviews were conducted with a purposive sample of patient survey respondents. Eligible providers were surveyed by email, resulting in a 3% response rate (78 providers). Survey data were analyzed descriptively and using multivariable regression models. Interview data were analyzed thematically.
Results: Of 213 patients with an adherence score available, 31.5% reported non-adherence. Nonadherent patients were more likely to report poor healthcare experiences, including discrimination in a healthcare setting and poorer mental/emotional health. Receiving information from providers was significantly associated with adherence, especially among younger patients and those with fewer chronic conditions. High self-efficacy score was associated with adherence, particularly among older and rural patients. Interview analyses showed provider communication about AF medications, perceptions of AF as a serious illness, and a sense that medication was helping manage AF were all important for medication adherence. In contrast, most providers (87%) perceived high non-adherence among AF patients, citing forgetfulness, cost, and side effects as the main reasons. Providers’ responses indicate a need for improving communication and support for addressing adherence barriers.
Conclusion: Most patients reported adherence to their medications, with adherence being associated with positive healthcare experiences and better mental/emotional health. Providers perceived relatively low adherence among their patients but aligned with patients on the need for improved communication and shared decision making. Tools that encourage discussion with patients and open communication between providers and patients are pivotal for optimizing patient care and enhancing medication adherence and treatment outcomes.
  • Gill, Monique  ( Providence Health & Services , Portland , Oregon , United States )
  • Manzey, Laura  ( Pfizer, Inc. , New York , New York , United States )
  • Townsend, Kevin  ( Self-Employed , Chelsea , Michigan , United States )
  • Wendt, Staci  ( Providence Research Network , Renton , Washington , United States )
  • Jones, Kyle  ( Providence Health & Services , Portland , Oregon , United States )
  • Ghosal, Ritu  ( Providence Health & Services , Portland , Oregon , United States )
  • Gilmore, Aisha  ( Providence Health & Services , Portland , Oregon , United States )
  • Johnson, Angela  ( Providence Research Network , Renton , Washington , United States )
  • Wilson, Eleni  ( Providence Health and Services , Renton , Washington , United States )
  • Imboden, Mary  ( Providence Heart Insitute , Portland , Oregon , United States )
  • Ateya, Mohammad  ( Pfizer, Inc. , New York , New York , United States )
  • Dai, Feng  ( Pfizer, Inc. , New York , New York , United States )
  • Author Disclosures:
    Monique Gill: DO NOT have relevant financial relationships | Laura Manzey: DO have relevant financial relationships ; Employee:Pfizer Inc.:Active (exists now) ; Individual Stocks/Stock Options:Pfizer Inc.:Active (exists now) | Kevin Townsend: No Answer | Staci Wendt: DO NOT have relevant financial relationships | Kyle Jones: DO NOT have relevant financial relationships | Ritu Ghosal: No Answer | Aisha Gilmore: DO NOT have relevant financial relationships | Angela Johnson: DO NOT have relevant financial relationships | Eleni Wilson: DO NOT have relevant financial relationships | Mary Imboden: No Answer | Mohammad Ateya: DO have relevant financial relationships ; Employee:Pfizer Inc.:Active (exists now) | Feng Dai: DO have relevant financial relationships ; Employee:Pfizer Inc.:Active (exists now) ; Individual Stocks/Stock Options:Pfizer Inc.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Data to Discovery: Novel Methods in Cardiovascular Outcomes Research

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts from these authors:
A Machine Learning Approach to Simplify Risk Stratification of Patients with Atherosclerotic Cardiovascular Disease

Li Hsin Fang, Gluckman Ty, Nute Andrew, Weerasinghe Roshanthi, Wendt Staci, Wilson Eleni, Sidelnikov Eduard, Kathe Niranjan, Swihart Charissa, Jones Laney

You have to be authorized to contact abstract author. Please, Login
Not Available